Review for family doctors: cannabis helps chronic and nerve pain but carries addiction risk and psychotropic side effects
A review for family physicians found clinical evidence supporting cannabis for chronic and neuropathic pain, while noting synergistic cannabinoid-opioid interactions could potentially reduce drug-seeking behavior.
Quick Facts
What This Study Found
The review provided a practical update for family physicians on medical cannabis, covering several key points.
Clinical trials demonstrated benefits for alleviating chronic and neuropathic pain, though significant psychotropic and physical side effects accompanied use. The addiction potential was acknowledged.
Recent laboratory data highlighted synergistic interactions between cannabinoid and opioid receptors. These interactions had two important implications: potential reduction in drug-seeking behavior and opioid-sparing effects (lower opioid doses needed when combined with cannabinoids).
The legal landscape was changing, with certain US states permitting medical marijuana, and family physicians needed practical knowledge about the pros, cons, legal implications, and future developments.
Key Numbers
The review covered clinical trial evidence for chronic and neuropathic pain without reporting specific pooled effect sizes.
How They Did This
Narrative review for the Journal of the American Board of Family Medicine, synthesizing clinical trial evidence, pharmacology, and sociological context of medical cannabis for primary care physicians.
Why This Research Matters
As the front line of patient care, family physicians needed balanced, practical information about medical cannabis to counsel patients appropriately in a changing legal landscape.
The Bigger Picture
The cannabinoid-opioid synergy findings were particularly relevant given the emerging opioid crisis, suggesting cannabis might reduce reliance on opioid painkillers.
What This Study Doesn't Tell Us
Narrative review for a clinical audience, not a systematic evidence synthesis. The legal and regulatory landscape described was specific to 2011 and has changed substantially.
Questions This Raises
- ?Can cannabis-opioid combinations safely reduce opioid prescribing?
- ?How should family physicians counsel patients about medical cannabis in states where it is legal?
Trust & Context
- Key Stat:
- Cannabinoid-opioid synergy could produce opioid-sparing effects
- Evidence Grade:
- Clinical narrative review synthesizing available evidence for a primary care audience.
- Study Age:
- Published in 2011. The medical cannabis landscape, legal framework, and evidence base have changed dramatically since.
- Original Title:
- Cannabis and its derivatives: review of medical use.
- Published In:
- Journal of the American Board of Family Medicine : JABFM, 24(4), 452-62 (2011)
- Authors:
- Leung, Lawrence
- Database ID:
- RTHC-00503
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What does the evidence say about cannabis for pain?
Clinical trials supported cannabis for chronic and neuropathic pain, with the potential bonus of cannabinoid-opioid synergy that could reduce opioid doses needed. However, psychotropic side effects and addiction potential were also documented.
Could cannabis reduce the need for opioid painkillers?
Laboratory data showed synergistic interactions between cannabinoid and opioid receptors, suggesting combination therapy could achieve pain relief with lower opioid doses. Clinical evidence for this approach was still developing.
Read More on RethinkTHC
- CBD-oil-quality-guide
- anxiety-medication-after-quitting-weed
- cannabis-chemotherapy-nausea
- cannabis-chronic-pain-research
- cannabis-epilepsy-CBD-Epidiolex
- cbd-anxiety-research-evidence
- cbd-for-weed-withdrawal
- cbd-vs-thc-difference
- medical-benefits-of-cannabis
- quitting-weed-before-surgery
- quitting-weed-medication-interactions
- quitting-weed-pregnancy
- quitting-weed-pregnant
- seniors-older-adults-cannabis-risks-medications
- weed-breastfeeding-THC-breast-milk
Cite This Study
https://rethinkthc.com/research/RTHC-00503APA
Leung, Lawrence. (2011). Cannabis and its derivatives: review of medical use.. Journal of the American Board of Family Medicine : JABFM, 24(4), 452-62. https://doi.org/10.3122/jabfm.2011.04.100280
MLA
Leung, Lawrence. "Cannabis and its derivatives: review of medical use.." Journal of the American Board of Family Medicine : JABFM, 2011. https://doi.org/10.3122/jabfm.2011.04.100280
RethinkTHC
RethinkTHC Research Database. "Cannabis and its derivatives: review of medical use." RTHC-00503. Retrieved from https://rethinkthc.com/research/leung-2011-cannabis-and-its-derivatives
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.